Moderna defends vax price hike, despite billions in taxpayer funding

ViewThe head of Moderna is defending his company's decision to raise the price of its COVID-19 vaccine fivefold, despite receiving funding for research and development from the U.S. government.

Moderna CEO Stephane Bancel testified before the Senate Health, Education, Labor, and Pensions committee on Wednesday over the...